M. Pourshadi et al., ABROGATION OF SECONDARY SKIN ALLOGRAFT-REJECTION BY VETO-LIKE CELLS IN DONOR BONE-MARROW, Transplantation, 56(2), 1993, pp. 385-390
To investigate whether a veto cell phenomenon is involved in the abili
ty of donor strain bone marrow cells (BMC) to inactivate second-set sk
in graft rejection induced by the adoptive transfer of sensitized sple
en cells (SSC), mice were grafted with ear skin allografts and injecte
d on the following day with recipient strain SSC or SSC plus donor str
ain BMC. When skin and BMC donors from an F1 strain (B6AF1) were combi
ned with a parental strain (C57BL/6) as recipient and SSC donors, the
BMC were fully active in abrogating second-set rejection even though t
he SSC were naturally tolerant of the BMC. Thus, immunological recogni
tion of the SSC by the BMC is not necessary for this abrogation. The s
uppressive activity of the BMC is specific in a manner similar to that
reported for veto cells (i.e., they suppress an anti-self response).
If BMC from various strains of mice were used to alter the rejection o
f C3H grafts by B6AF1 recipients, only BMC expressing the MHC antigens
to which the SSC had been sensitized significantly suppressed the act
ivity of SSC. Sharing of additional antigens between the graft and BMC
(e.g., MHC antigens not recognized by the SSC or minor antigens) was
neither necessary nor sufficient. Mitomycin C-treated BMC were unable
to inhibit SSC-induced accelerated rejection. Overall, the characteris
tics of the SSC-suppressive activity of BMC are consistent with a veto
cell nature of the BMC.